Review warns cannabis exposure in autistic individuals may increase psychosis risk through epigenetic mechanisms
Autism spectrum individuals may be particularly vulnerable to cannabis-induced psychosis due to epigenetic effects on shared genetic pathways, with potential intergenerational consequences.
Quick Facts
What This Study Found
Cannabis exposure in autistic individuals may exert disruptive epigenetic effects on brain regions critical to schizophrenia pathophysiology. Autism candidate genes carry bivalent chromatin markings that make them more vulnerable to cannabinoid-induced disruption. These epigenetic changes could potentially be inherited intergenerationally, supporting a developmental trajectory between autism and psychosis modulated by the endocannabinoid system.
Key Numbers
The review does not provide specific prevalence numbers but identifies autism candidate genes with bivalent chromatin markings as a molecular vulnerability.
How They Did This
Narrative review synthesizing evidence on cannabinoid-induced epigenetic effects in autism spectrum individuals, focusing on shared genetic pathways between autism and psychosis and the role of the endocannabinoid system.
Why This Research Matters
As cannabis use becomes more common, including among autistic individuals seeking symptom relief, understanding population-specific risks is crucial, especially when those risks may extend to future generations.
The Bigger Picture
The intersection of autism, cannabis, and psychosis risk represents an emerging area where genetic predisposition, epigenetic vulnerability, and substance exposure may converge, challenging one-size-fits-all approaches to cannabis policy.
What This Study Doesn't Tell Us
Much of the evidence is from preclinical models. The proposed intergenerational epigenetic inheritance has limited direct evidence in humans. The review does not quantify the actual risk increase. Narrative rather than systematic review.
Questions This Raises
- ?What is the actual magnitude of psychosis risk for autistic cannabis users?
- ?Are there safe cannabinoid compounds (like CBD) for this population?
- ?How strong is the evidence for intergenerational epigenetic transmission?
Trust & Context
- Key Stat:
- Autism genes carry epigenetic markings vulnerable to cannabinoid disruption
- Evidence Grade:
- Narrative review drawing on preclinical and genetic evidence. The proposed mechanisms are plausible but largely unconfirmed in humans.
- Study Age:
- Published in 2022.
- Original Title:
- Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.
- Published In:
- Healthcare (Basel, Switzerland), 10(8) (2022)
- Authors:
- Bortoletto, Riccardo(2), Colizzi, Marco(10)
- Database ID:
- RTHC-03723
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Are autistic people more vulnerable to cannabis-related psychosis?
This review presents evidence suggesting they may be, due to epigenetic vulnerabilities in autism-related genes that make them more susceptible to cannabinoid-induced disruption in brain areas involved in psychosis.
Could cannabis effects be passed to future generations?
The review suggests that cannabis-induced epigenetic changes in autistic individuals could theoretically be inherited, but this remains a hypothesis with limited direct human evidence.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03723APA
Bortoletto, Riccardo; Colizzi, Marco. (2022). Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.. Healthcare (Basel, Switzerland), 10(8). https://doi.org/10.3390/healthcare10081553
MLA
Bortoletto, Riccardo, et al. "Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.." Healthcare (Basel, 2022. https://doi.org/10.3390/healthcare10081553
RethinkTHC
RethinkTHC Research Database. "Cannabis Use in Autism: Reasons for Concern about Risk for P..." RTHC-03723. Retrieved from https://rethinkthc.com/research/bortoletto-2022-cannabis-use-in-autism
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.